Neurology & Neuroscience Associates, Inc.

Akron, Ohio 44320

0 studies enrolling now · 9 studies all time

What they study most

Clinically Isolated Syndrome, Cognition Disorders, Migraine, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Parkinson's Disease Dementia, Relapsing-Remitting Multiple Sclerosis

Studies at this site

• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
• Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy — NO_LONGER_AVAILABLE
• Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase — Completed
• Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis — Stopped early
• Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects — Completed
• Autologous T Cell Vaccine (TCV) for Multiple Sclerosis — Completed
• Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis — Completed
• Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) — Completed
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis — Completed